Topic · page 22 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 841–880 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Lancet Rheumatol8 Mar 2025
Diagnostic, research, and real-life effect of the 2023 EULAR−ACR classification criteria for antiphospholipid syndrome
Research article
Semin Arthritis Rheum7 Mar 2025
Molecular mechanisms underlying thrombosis in systemic lupus erythematosus – A Systematic review
Meta-analysis
Arthritis Care Res (Hoboken)7 Mar 2025
Predictors of Mortality in Antiphospholipid Antibody–Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository
Cohort study
Arthritis Care Res (Hoboken)7 Mar 2025
Temporal Trends and Demographic Insights Into Mortality From Systemic Lupus Erythematosus, 1999–2020
Cross-sectional study
Semin Arthritis Rheum6 Mar 2025
Prevalence of frailty and prefrailty in systemic lupus erythematosus: A systematic review and meta-analysis
Meta-analysis
Lupus Sci Med5 Mar 2025
Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren’s disease: Prepcov multicentre trial
Cohort study
Lupus Sci Med5 Mar 2025
Systematic review of the reporting of extrarenal manifestations in observational studies of Saudi patients with systemic lupus erythematosus
Meta-analysis
Lupus4 Mar 2025
Health journey of Nigerian patients with systemic lupus erythematosus
Cross-sectional study
Lupus4 Mar 2025
Prognostic value of the modified National Institute of health activity and chronicity scoring system in predicting end-stage kidney disease in Latin American lupus nephritis patients
Cohort study
Rheumatology (Oxford)3 Mar 2025
Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world setting
Cohort study
JAMA Netw Open3 Mar 2025
Mizoribine or Cyclophosphamide for Lupus Nephritis: A Randomized Clinical Trial
Randomized controlled trial
Lupus2 Mar 2025
Clinical features of anti-ribosomal P protein antibodies in systemic lupus erythematosus: A single-center retrospective study in China
Case-control study
Arthritis Res Ther1 Mar 2025
Unraveling the role of lncRNAs and their associated nearby coding genes in the pathogenesis of systemic lupus erythematosus
Mechanistic study
Ann Rheum Dis28 Feb 2025
Three years is the minimal effective duration of sustained clinical remission which prevents impaired kidney function and damage accrual in lupus nephritis
Cohort study
Lupus27 Feb 2025
Impact of SARS-CoV-2 pre-delta/delta and omicron variants on clinical outcomes in a systemic lupus erythematosus cohort from Puerto Rico
Cohort study
Lupus27 Feb 2025
Infant feeding experiences of women with systemic lupus erythematosus: A qualitative study
Research article
Ann Rheum Dis27 Feb 2025
Responsiveness of systemic lupus erythematosus subjects to iberdomide based on molecular endotypes
Secondary analysis
Semin Arthritis Rheum27 Feb 2025
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set
Research article
Lupus Sci Med26 Feb 2025
Development and evaluation of a Register-Based Organ Damage Index in systemic lupus erythematosus: a nationwide, population-based study from Sweden
Diagnostic or prognostic study
Lupus Sci Med26 Feb 2025
Mortality patterns of SLE and the associated risk factors in Korean patients: a nationwide cohort study
Cohort study
Lupus Sci Med26 Feb 2025
Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
Cohort study
RMD Open26 Feb 2025
Association of peripheral CD8 + T cell activation with disease activity and treatment resistance in systemic lupus erythematosus
Cohort study
Arthritis Res Ther26 Feb 2025
Blood gene expression of Toll-like receptors in SLE patients with lupus nephritis or neuropsychiatric systemic lupus erythematosus
Cross-sectional study
Semin Arthritis Rheum25 Feb 2025
Risk and triggering factors for diffuse alveolar hemorrhage in primary antiphospholipid syndrome. An observational follow-up study and a systematic review of the literature
Meta-analysis
Lupus25 Feb 2025
Distinctive cerebral small vessel disease patterns are associated with ischemic stroke in systemic lupus erythematosus
Cohort study
Rheumatology (Oxford)25 Feb 2025
Identified genetic locus for longitudinal disease activity in adults with systemic lupus erythematosus
Meta-analysis
Ann Rheum Dis24 Feb 2025
Increased healthcare utilisation in the 5 years preceding systemic lupus erythematosus diagnosis: a Danish nationwide cohort study
Cohort study
RMD Open23 Feb 2025
Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study
Cohort study
Clin Exp Rheumatol23 Feb 2025
Clinical adverse events to voclosporin: a real-world drug safety study based on FDA Adverse Event Reporting System
Cohort study
Rheumatology (Oxford)22 Feb 2025
Treat-to-target in SLE: is serology important? Results from an integrated analysis of five randomized clinical trials of belimumab
Secondary analysis
Lupus21 Feb 2025
Association of low-grade proteinuria with changes of lupus nephritis in kidney biopsy in SLE patients
Cohort study
Lupus20 Feb 2025
Risk factors for bleeding in patients with thrombotic antiphospholipid syndrome during antithrombotic therapy
Cohort study
Lupus19 Feb 2025
In-hospital outcomes of patients with antiphospholipid syndrome undergoing transcatheter and surgical aortic valve replacement: A population-based analysis of national inpatient sample from 2015–2021
Cohort study
Lupus Sci Med18 Feb 2025
Real-world oral glucocorticoid use in SLE: a nation-wide population-based study using the French medico-administrative (SNDS) claim database
Cross-sectional study
Lupus Sci Med18 Feb 2025
Autoimmune encephalitis associated with anti-LGI1 antibody: a potential cause of neuropsychiatric systemic lupus erythematosus
Cohort study
Semin Arthritis Rheum14 Feb 2025
Advanced imaging in the evaluation of lupus arthritis: A systematic literature review and meta-analysis
Meta-analysis
Lupus Sci Med13 Feb 2025
Identification and functional characterisation of a novel DNASE1L3 variant (c.572A>G, p.Asn191Ser) in three Emirati families with systemic lupus erythematosus and hypocomplementaemic urticarial vasculitis
Mechanistic study
Lupus Sci Med13 Feb 2025
Prediction of mortality risk in critically ill patients with systemic lupus erythematosus: a machine learning approach using the MIMIC-IV database
Diagnostic or prognostic study
Lupus Sci Med12 Feb 2025
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report
Research article
Lupus Sci Med12 Feb 2025
Time trends of variability in disease activity in systemic lupus erythematosus
Cohort study

All 1,848 Briefs in ExploreShowing Briefs 841–880 of 1,848, newest first